Walgreens is helping its primary care partners reduce errors and speed up the reimbursement process as health execs plan to adopt RCM and billing tech.
SureScripts highlights how incomplete data can delay patients from receiving specialty medication and contributes to provider stress.
Trilliant Health’s AI tool scores hospitals based on evidence-based data—which is more reliable than scores given by agencies like CMS.
We detail the challenges the top meditation apps could face this year.
We detail why Amazon’s new D2C telehealth service could have an easier time taking off than Amazon Care did, and how it could threaten companies like Ro.
Juul’s costly settlement offers a lesson to marketers: Company to pay $438.5 million and faces stiff sales restrictions after probe into underage vaping.
We forecast that there will be over 25 million US Apple Watch users this year, nearly half of all US smartwatch users. But Apple is seeking a bigger piece of the pie, leaning into health and safety features with its latest Watch devices to attract new (and current) users.
An HHS OIG report highlights the geography of telehealth and the need to boost access in rural areas.
We detail why Signify Health’s physician network is important to CVS, and how the purchase will help Aetna contend with Humana.
Value-based care for seniors and Medicare members helps Walmart keep pace with Walgreens and CVS.
GoodRx trims 16% of its workforce as digital health companies contend with the economic fallout.
Virtual Incision’s plans for a robotic space visit highlight the need to make digital surgery devices much smaller.
On today's episode, we discuss what brand new forecasts the forecasting team cooked up in Q2, including influencer marketing spend by platform and tier, luxury ecommerce, and US prescription drug sales. "In Other News," we talk about Apple Pay's meteoric rise and what DoorDash's Q2 performance says about the future of the food delivery space. Tune in to the discussion with our senior forecasting analyst Iwona Drapala and director of forecasting Peter Newman.